CSIMarket Company Name, Ticker, Suppliers, else..
 
Asp Isotopes Inc   (NASDAQ: ASPI)
 
Price: $4.2000 $0.30 7.692%
Day's High: $4.264999866485596 Week Perf: 4.48 %
Day's Low: $ 3.91 30 Day Perf: 2.44 %
Volume (M): 3,830,199 52 Wk High: $ 14.49
Volume (M$): $ 0 52 Wk Avg: $6.38
Open: $3.91 52 Wk Low: $3.51



 Market Capitalization (Millions $) 515
 Shares Outstanding (Millions) 123
 Employees 271
 Revenues (TTM) (Millions $) 31
 Net Income (TTM) (Millions $) -117
 Cash Flow (TTM) (Millions $) 146
 Capital Exp. (TTM) (Millions $) 16

Business Description


Asp Isotopes Inc is a company that specializes in the production and distribution of stable isotopes for scientific and medical research purposes. They offer a wide range of isotopes, including carbon, nitrogen, oxygen, and hydrogen, which are commonly used in various fields of study. The company is known for its high-quality isotopes and reliable supply chain, ensuring that researchers have access to the materials they need. Asp Isotopes Inc also provides custom synthesis services, allowing researchers to request specific isotopes that may not be readily available.


   Company Address: 2200 Ross Avenue Dallas 75201 TX
   Company Phone Number: 432-8219   Stock Exchange / Ticker: NASDAQ ASPI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Washington, D.C. 13 October 2025 ASP Isotopes Inc. (NASDAQ ASPI), a pioneer in the advanced materia...

Published Tue, Oct 14 2025 8:31 AM UTC

ASP Isotopes Accelerates Growth with Major Supply Agreement and Strategic Acquisition Washington, D.C. 13 October 2025 ASP Isotopes Inc. (NASDAQ: ASPI), a pioneer in the advanced materials sector focused on isotope production, has announced significant progress in its business development strategy with two groundbreaking initiatives. The company reported the establishm...
Announcement

“Investors on Alert Class Action Lawsuit Targets ASP Isotopes Amid Market Uncertainty”,

Published Fri, Jan 31 2025 9:11 PM UTC

CSIMarket.com Deadline Looms for ASP Isotopes Investors Amid Class Action Lawsuit As the clock ticks down to a critical deadline next week, investors in ASP Isotopes Inc. (NASDAQ: ASPI) are advised to take immediate action. On January 31, 2025, the well-respected law firm Berger Montague PC announced it is leading a class action lawsuit on behalf of investors who purchase...
Announcement

ASP Isotopes (ASPI) Share Price Falls 40% Following Short Seller Report, Despite Companys Rebuttal,

Published Wed, Jan 22 2025 9:12 PM UTC

ASP Isotopes (ASPI) Continues to Struggle Despite Efforts to Counteract Short Seller Attack SAN FRANCISCO, Jan. 22, 2025 ASP Isotopes Inc. (NASDAQ: ASPI) has found itself grappling with a significant decline in its stock price, a situation exacerbated by a recent report from activist short-seller Fuzzy Panda Research. In the past five days alone, ASPI shares have plummet...
Management Announcement

ASP Isotopes Inc. Hosts Investor Event Amidst $27 Million Loss and Class Action Lawsuit Threat,

Published Mon, Jan 13 2025 3:31 PM UTC

ASP Isotopes Inc. Faces Legal Challenges Amid Investor Updates in South AfricaThis week, ASP Isotopes Inc. (NASDAQ: ASPI) welcomed a global group of institutional investors to its facilities in Pretoria, South Africa, for a two-day investor access event. The event was aimed at providing updates on the company s ongoing projects, particularly its Silicon-28, Ytterbium-176, a...
Announcement

Upcoming Class Action Lawsuit Alerts ASP Isotopes Inc. Investors

Published Wed, Jan 8 2025 8:27 PM UTC

In a significant recent development for investors of ASP Isotopes Inc. (NASDAQ: ASPI), Levi & Korsinsky, LLP has announced a pending class action securities lawsuit against the company, reminding affected investors of the critical lead plaintiff deadline set for February 3, 2025. This notification underscores the legal concerns surrounding ASP Isotopes and the implications f...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 16.71
Price to Sales (Expected) -
Price to Book 1.88
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.63
Working Capital Ratio 3.81
Leverage Ratio (MRQ) 1.25
Total Debt to Equity 1.16
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.24 $
Revenues (TTM) 0.25 $
Cash Flow (TTM) 1.19 $
Cash 2.08 $
Book Value 2.24 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 113,845
Net Income per Employee (TTM) -432,983
Receivable Turnover Ratio (TTM) 3.03
Inventory Turnover Ratio (TTM) 18.79
Asset Turnover Ratio (TTM) 0.07

Profitability Ratios Current
Gross Margin (MRQ) 28.89 %
Operating Margin (MRQ) -667.48 %
Net Margin (MRQ) -663.54 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Asp Isotopes Inc's Segments
Product    165.98 % of total Revenue
Helium and LNG Product Revenue    24.36 % of total Revenue
ZA    117.65 % of total Revenue
Specialist isotopes and related services Product Revenue    63.95 % of total Revenue
Specialist isotopes and related services    141.62 % of total Revenue
Total Segment    181.59 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.